These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 5312376)
21. [The use of anti-inflammatory drugs in rheumopathies]. Hart FD Clin Ter; 1967 Jan; 40(1):3-12. PubMed ID: 5303972 [No Abstract] [Full Text] [Related]
22. Anti-inflammatory effect of oxyphenbutazone on episiotomy healing. David MP; Boiman O; Avni A Int Surg; 1976 Oct; 61(20):555-6. PubMed ID: 789279 [No Abstract] [Full Text] [Related]
23. [Mechanism of action of a new anti-inflammatory analgesic drug in some eye disorders]. Manusia M Minerva Oftalmol; 1967; 9(4):137-9. PubMed ID: 9082246 [No Abstract] [Full Text] [Related]
24. [Clinical evaluation on the use of oxyphenbutazone and indomethacin in vaginal surgery]. Lara Arceo JF; Lopez Alatorre I; Moran Gonzalez R Prensa Med Mex; 1969; 34(9):385-7. PubMed ID: 4907857 [No Abstract] [Full Text] [Related]
25. [Considerations on the therapy of phlogoses with non-steroid anti-inflammatory drugs]. Cairella M; Marasà G Clin Ter; 1968 Oct; 47(2):187-95. PubMed ID: 4883995 [No Abstract] [Full Text] [Related]
26. An audit of calls to a specialist nurse-led rheumatology advice line related to antibiotic treatment and biological therapies. Swan J; Bond U; O'Connor MB; Phelan MJ Rheumatol Int; 2014 Mar; 34(3):417. PubMed ID: 23615627 [No Abstract] [Full Text] [Related]
27. [A CONTRIBUTION TO THE ANTIPHLOGISTIC EFFECT OF TANDERIL, BUTAZOLIDINE AND DELTA-BUTAZOLIDINE]. HIEMEYER V Med Klin; 1963 Dec; 58():2095-7. PubMed ID: 14115095 [No Abstract] [Full Text] [Related]
28. Epididymitis. Response to different modalities of treatment. Kamat MH; Del Gaizo A; Seebode JJ J Med Soc N J; 1970 May; 67(5):227-9. PubMed ID: 5293532 [No Abstract] [Full Text] [Related]
29. [Tanderil as an adjuvant in antiobiotic therapy]. Adjan M Ther Ggw; 1971 Jun; 110(6):863-5 passim. PubMed ID: 5089484 [No Abstract] [Full Text] [Related]
30. [Present data on inflammation. III. Experimentally induced inflammation (author's transl)]. Dayrens P; Ivanoff B; Cussac M; Fontanges R Sem Hop; 1980 May 18-25; 56(19-20):995-1003. PubMed ID: 6251568 [TBL] [Abstract][Full Text] [Related]
31. [Various problems of chronopharmacology and chronotherapy at present]. Zaslavskaia RM; Olevskiĭ IKh; Duda SG Ter Arkh; 1985; 57(12):89-93. PubMed ID: 4089775 [No Abstract] [Full Text] [Related]
32. [Use of oxyphenylbutazone in rheumatic diseases]. Roimicher S; Azevedo MN; Pereira Filho O Rev Bras Med; 1968 Jul; 25(7):477-80. PubMed ID: 5308619 [No Abstract] [Full Text] [Related]
34. [Studies on the tolerance of Realin in rheumatic diseases]. Grimm-Strang M; Kwoczek J Med Monatsschr; 1972 Apr; 26(4):180-2. PubMed ID: 4537547 [No Abstract] [Full Text] [Related]
35. Activity and tolerance of oxamethacin. Verhaegen H Methods Find Exp Clin Pharmacol; 1982; 4(8):617-23. PubMed ID: 6763119 [No Abstract] [Full Text] [Related]
36. [Results of comparative clinical examinations of antirheumatics: clofezone, indomethacin, phenylbutazone]. Keitel W; Weber G; Hoffmann H Schweiz Rundsch Med Prax; 1971 Jan; 60(1):18-21. PubMed ID: 5313620 [No Abstract] [Full Text] [Related]
37. [Infections and rheumatic diseases: a view of the problem in the beginning of XXI century]. Belov BS; Balabanov RM; Manukian SG; Polianskaia MV Vestn Ross Akad Med Nauk; 2008; (6):14-8. PubMed ID: 18652198 [TBL] [Abstract][Full Text] [Related]